Skip to main content
PMC home page
Sexually Transmitted Infections logoLink to Sexually Transmitted Infections
. 2004 Aug;80(4):255–263. doi: 10.1136/sti.2004.009415

Recent trends in the epidemiology of sexually transmitted infections in the European Union

K Fenton 1, C Lowndes 1
PMCID: PMC1744866  PMID: 15295121

Full Text

The Full Text of this article is available as a PDF (136.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adler M. W., Meheust A. Z. Epidemiology of sexually transmitted infections and human immunodeficiency virus in Europe. J Eur Acad Dermatol Venereol. 2000 Sep;14(5):370–377. doi: 10.1046/j.1468-3083.2000.00088.x. [DOI] [PubMed] [Google Scholar]
  2. Arvaja M., Lehtinen M., Koskela P., Lappalainen M., Paavonen J., Vesikari T. Serological evaluation of herpes simplex virus type 1 and type 2 infections in pregnancy. Sex Transm Infect. 1999 Jun;75(3):168–171. doi: 10.1136/sti.75.3.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bauer H. M., Hildesheim A., Schiffman M. H., Glass A. G., Rush B. B., Scott D. R., Cadell D. M., Kurman R. J., Manos M. M. Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon. Sex Transm Dis. 1993 Sep-Oct;20(5):274–278. doi: 10.1097/00007435-199309000-00007. [DOI] [PubMed] [Google Scholar]
  4. Berglund T., Fredlund H., Giesecke J. Epidemiology of the reemergence of gonorrhea in Sweden. Sex Transm Dis. 2001 Feb;28(2):111–114. doi: 10.1097/00007435-200102000-00009. [DOI] [PubMed] [Google Scholar]
  5. Berglund T., Fredlund H., Ramstedt K. Reemergence of gonorrhea in Sweden. Sex Transm Dis. 1999 Aug;26(7):390–391. doi: 10.1097/00007435-199908000-00005. [DOI] [PubMed] [Google Scholar]
  6. Berglund Torsten, Unemo Magnus, Olcén Per, Giesecke Johan, Fredlund Hans. One year of Neisseria gonorrhoeae isolates in Sweden: the prevalence study of antibiotic susceptibility shows relation to the geographic area of exposure. Int J STD AIDS. 2002 Feb;13(2):109–114. doi: 10.1258/0956462021924730. [DOI] [PubMed] [Google Scholar]
  7. Burk R. D., Kelly P., Feldman J., Bromberg J., Vermund S. H., DeHovitz J. A., Landesman S. H. Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis. 1996 Jul-Aug;23(4):333–341. doi: 10.1097/00007435-199607000-00013. [DOI] [PubMed] [Google Scholar]
  8. Chesson Harrell W., Dee Thomas S., Aral Sevgi O. AIDS mortality may have contributed to the decline in syphilis rates in the United States in the 1990s. Sex Transm Dis. 2003 May;30(5):419–424. doi: 10.1097/00007435-200305000-00008. [DOI] [PubMed] [Google Scholar]
  9. Cuzick J., Beverley E., Ho L., Terry G., Sapper H., Mielzynska I., Lorincz A., Chan W. K., Krausz T., Soutter P. HPV testing in primary screening of older women. Br J Cancer. 1999 Oct;81(3):554–558. doi: 10.1038/sj.bjc.6690730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cuzick J., Szarewski A., Terry G., Ho L., Hanby A., Maddox P., Anderson M., Kocjan G., Steele S. T., Guillebaud J. Human papillomavirus testing in primary cervical screening. Lancet. 1995 Jun 17;345(8964):1533–1536. doi: 10.1016/s0140-6736(95)91086-7. [DOI] [PubMed] [Google Scholar]
  11. Dodds J. P., Nardone A., Mercey D. E., Johnson A. M. Increase in high risk sexual behaviour among homosexual men, London 1996-8: cross sectional, questionnaire study. BMJ. 2000 Jun 3;320(7248):1510–1511. doi: 10.1136/bmj.320.7248.1510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Doherty Lorraine, Fenton Kevin A., Jones Jane, Paine Thomas C., Higgins Stephen P., Williams Deborah, Palfreeman Adrian. Syphilis: old problem, new strategy. BMJ. 2002 Jul 20;325(7356):153–156. doi: 10.1136/bmj.325.7356.153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Eskild A., Jeansson S., Jenum P. A. Herpes simplex-virus type 2-antistoffer hos gravide i Norge. Tidsskr Nor Laegeforen. 1999 Jun 20;119(16):2323–2326. [PubMed] [Google Scholar]
  14. Fenton K. A., Nicoll A., Kinghorn G. Resurgence of syphilis in England: time for more radical and nationally coordinated approaches. Sex Transm Infect. 2001 Oct;77(5):309–310. doi: 10.1136/sti.77.5.309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Figueroa J. P., Ward E., Luthi T. E., Vermund S. H., Brathwaite A. R., Burk R. D. Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity. Sex Transm Dis. 1995 Mar-Apr;22(2):114–118. doi: 10.1097/00007435-199503000-00007. [DOI] [PubMed] [Google Scholar]
  16. Forsgren M., Skoog E., Jeansson S., Olofsson S., Giesecke J. Prevalence of antibodies to herpes simplex virus in pregnant women in Stockholm in 1969, 1983 and 1989: implications for STD epidemiology. Int J STD AIDS. 1994 Mar-Apr;5(2):113–116. doi: 10.1177/095646249400500207. [DOI] [PubMed] [Google Scholar]
  17. Franco E., Caprilli F., Zaratti L., Pasquini P. Prevalence of antibodies to herpes simplex virus type 1 in different population groups in Italy. Eur J Clin Microbiol. 1987 Jun;6(3):322–322. doi: 10.1007/BF02017628. [DOI] [PubMed] [Google Scholar]
  18. García-Corbeira P., Dal-Ré R., Aguilar L., Granizo J. J., García-de-Lomas J. Is sexual transmission an important pattern for herpes simplex type 2 virus seroconversion in the Spanish general population? J Med Virol. 1999 Oct;59(2):194–197. doi: 10.1002/(sici)1096-9071(199910)59:2<194::aid-jmv11>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  19. Gil A., González A., Dal-Ré R., Ortega P., Dominguez V. Prevalence of antibodies against varicella zoster, herpes simplex (types 1 and 2), hepatitis B and hepatitis A viruses among Spanish adolescents. J Infect. 1998 Jan;36(1):53–56. doi: 10.1016/s0163-4453(98)93126-7. [DOI] [PubMed] [Google Scholar]
  20. Green M. S., Anis E., Gandacu D., Grotto I. The fall and rise of gonorrhoea incidence in Israel: an international phenomenon? Sex Transm Infect. 2003 Apr;79(2):116–118. doi: 10.1136/sti.79.2.116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Grussendorf-Conen E. I., Meinhof W., de Villiers E. M., Gissmann L. Occurrence of HPV genomes in penile smears of healthy men. Arch Dermatol Res. 1987;279 (Suppl):S73–S75. doi: 10.1007/BF00585925. [DOI] [PubMed] [Google Scholar]
  22. Hakama M., Lehtinen M., Knekt P., Aromaa A., Leinikki P., Miettinen A., Paavonen J., Peto R., Teppo L. Serum antibodies and subsequent cervical neoplasms: a prospective study with 12 years of follow-up. Am J Epidemiol. 1993 Jan 15;137(2):166–170. doi: 10.1093/oxfordjournals.aje.a116656. [DOI] [PubMed] [Google Scholar]
  23. Hiltunen-Back E., Rostila T., Kautiainen H., Paavonen J., Reunala T. Rapid decrease of endemic gonorrhea in Finland. Sex Transm Dis. 1998 Apr;25(4):181–186. doi: 10.1097/00007435-199804000-00001. [DOI] [PubMed] [Google Scholar]
  24. Hiltunen-Back Eija, Haikala Olli, Koskela Pentti, Vaalasti Annikki, Reunala Timo. Epidemics due to imported syphilis in Finland. Sex Transm Dis. 2002 Dec;29(12):746–751. doi: 10.1097/00007435-200212000-00002. [DOI] [PubMed] [Google Scholar]
  25. Hippeläinen M., Syrjänen S., Hippeläinen M., Koskela H., Pulkkinen J., Saarikoski S., Syrjänen K. Prevalence and risk factors of genital human papillomavirus (HPV) infections in healthy males: a study on Finnish conscripts. Sex Transm Dis. 1993 Nov-Dec;20(6):321–328. [PubMed] [Google Scholar]
  26. Hoffmann S. The laboratory surveillance system of Chlamydia trachomatis and Neisseria gonorrhoeae infections in Denmark. Euro Surveill. 2001 May;6(5):86–90. doi: 10.2807/esm.06.05.00211-en. [DOI] [PubMed] [Google Scholar]
  27. Jamison J. H., Kaplan D. W., Hamman R., Eagar R., Beach R., Douglas J. M., Jr Spectrum of genital human papillomavirus infection in a female adolescent population. Sex Transm Dis. 1995 Jul-Aug;22(4):236–243. doi: 10.1097/00007435-199507000-00007. [DOI] [PubMed] [Google Scholar]
  28. Jha P. K., Beral V., Peto J., Hack S., Hermon C., Deacon J., Mant D., Chilvers C., Vessey M. P., Pike M. C. Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk. Lancet. 1993 May 1;341(8853):1116–1118. doi: 10.1016/0140-6736(93)93128-n. [DOI] [PubMed] [Google Scholar]
  29. Johansen Jeanne Duus, Smith Else. Gonorrhoea in Denmark: high incidence among HIV-infected men who have sex with men. Acta Derm Venereol. 2002;82(5):365–368. doi: 10.1080/000155502320624104. [DOI] [PubMed] [Google Scholar]
  30. Johnson A. M., Fenton K. A., Mercer C. Phase specific strategies for the prevention, control, and elimination of sexually transmitted diseases: background country profile, England and Wales. Sex Transm Infect. 2002 Apr;78 (Suppl 1):i125–i132. doi: 10.1136/sti.78.suppl_1.i125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Johnson A. M., Mercer C. H., Erens B., Copas A. J., McManus S., Wellings K., Fenton K. A., Korovessis C., Macdowall W., Nanchahal K. Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours. Lancet. 2001 Dec 1;358(9296):1835–1842. doi: 10.1016/S0140-6736(01)06883-0. [DOI] [PubMed] [Google Scholar]
  32. Karlsson R., Jonsson M., Edlund K., Evander M., Gustavsson A., Bodén E., Rylander E., Wadell G. Lifetime number of partners as the only independent risk factor for human papillomavirus infection: a population-based study. Sex Transm Dis. 1995 Mar-Apr;22(2):119–127. doi: 10.1097/00007435-199503000-00008. [DOI] [PubMed] [Google Scholar]
  33. Kataoka A., Claesson U., Hansson B. G., Eriksson M., Lindh E. Human papillomavirus infection of the male diagnosed by Southern-blot hybridization and polymerase chain reaction: comparison between urethra samples and penile biopsy samples. J Med Virol. 1991 Mar;33(3):159–164. doi: 10.1002/jmv.1890330304. [DOI] [PubMed] [Google Scholar]
  34. Kenney J. W. Risk factors associated with genital HPV infection. Cancer Nurs. 1996 Oct;19(5):353–359. doi: 10.1097/00002820-199610000-00004. [DOI] [PubMed] [Google Scholar]
  35. Kjaer S. K., de Villiers E. M., Haugaard B. J., Christensen R. B., Teisen C., Møller K. A., Poll P., Jensen H., Vestergaard B. F., Lynge E. Human papillomavirus, herpes simplex virus and cervical cancer incidence in Greenland and Denmark. A population-based cross-sectional study. Int J Cancer. 1988 Apr 15;41(4):518–524. doi: 10.1002/ijc.2910410408. [DOI] [PubMed] [Google Scholar]
  36. Koutsky L. A., Galloway D. A., Holmes K. K. Epidemiology of genital human papillomavirus infection. Epidemiol Rev. 1988;10:122–163. doi: 10.1093/oxfordjournals.epirev.a036020. [DOI] [PubMed] [Google Scholar]
  37. Laporte A. A new decline in preventive behaviours among homosexual men : the role of highly active antiretroviral therapy? Euro Surveill. 2002 Feb;7(2):15–16. doi: 10.2807/esm.07.02.00349-en. [DOI] [PubMed] [Google Scholar]
  38. Lehtinen M., Dillner J., Knekt P., Luostarinen T., Aromaa A., Kirnbauer R., Koskela P., Paavonen J., Peto R., Schiller J. T. Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study. BMJ. 1996 Mar 2;312(7030):537–539. doi: 10.1136/bmj.312.7030.537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Lowndes C. M., Fenton K. A., European Surveillance of STI's Network Surveillance systems for STIs in the European Union: facing a changing epidemiology. Sex Transm Infect. 2004 Aug;80(4):264–271. doi: 10.1136/sti.2004.010389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Nicoll Angus, Hamers Françoise F. Are trends in HIV, gonorrhoea, and syphilis worsening in western Europe? BMJ. 2002 Jun 1;324(7349):1324–1327. doi: 10.1136/bmj.324.7349.1324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Olsen A. O., Orstavik I., Dillner J., Vestergaard B. F., Magnus P. Herpes simplex virus and human papillomavirus in a population-based case-control study of cervical intraepithelial neoplasia grade II-III. APMIS. 1998 Mar;106(3):417–424. doi: 10.1111/j.1699-0463.1998.tb01366.x. [DOI] [PubMed] [Google Scholar]
  42. Panchaud C., Singh S., Feivelson D., Darroch J. E. Sexually transmitted diseases among adolescents in developed countries. Fam Plann Perspect. 2000 Jan-Feb;32(1):24-32, 45. [PubMed] [Google Scholar]
  43. Parkes R., Renton A., Meheus A., Laukamm-Josten U. Review of current evidence and comparison of guidelines for effective syphilis treatment in Europe. Int J STD AIDS. 2004 Feb;15(2):73–88. doi: 10.1258/095646204322764253. [DOI] [PubMed] [Google Scholar]
  44. Pasquini P., Mele A., Franco E., Ippolito G., Svennerholm B. Prevalence of herpes simplex virus type 2 antibodies in selected population groups in Italy. Eur J Clin Microbiol Infect Dis. 1988 Feb;7(1):54–56. doi: 10.1007/BF01962174. [DOI] [PubMed] [Google Scholar]
  45. Persson K., Månsson A., Jönsson E., Nordenfelt E. Decline of herpes simplex virus type 2 and Chlamydia trachomatis infections from 1970 to 1993 indicated by a similar change in antibody pattern. Scand J Infect Dis. 1995;27(3):195–199. doi: 10.3109/00365549509019008. [DOI] [PubMed] [Google Scholar]
  46. Petzoldt D., Jappe U., Hartmann M., Hamouda O. Sexually transmitted diseases in Germany. Int J STD AIDS. 2002 Apr;13(4):246–253. doi: 10.1258/0956462021925045. [DOI] [PubMed] [Google Scholar]
  47. Roman A., Fife K. H. Human papillomaviruses: are we ready to type? Clin Microbiol Rev. 1989 Apr;2(2):166–190. doi: 10.1128/cmr.2.2.166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Smith Jennifer S., Robinson N. Jamie. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis. 2002 Oct 15;186 (Suppl 1):S3–28. doi: 10.1086/343739. [DOI] [PubMed] [Google Scholar]
  49. Stary A., Tomazic-Allen S., Choueiri B., Burczak J., Steyrer K., Lee H. Comparison of DNA amplification methods for the detection of Chlamydia trachomatis in first-void urine from asymptomatic military recruits. Sex Transm Dis. 1996 Mar-Apr;23(2):97–102. doi: 10.1097/00007435-199603000-00002. [DOI] [PubMed] [Google Scholar]
  50. Stolte G., Dukers N. H. T. M., de Wit J. B. F., Fennema H., Coutinho R. A. A summary report from Amsterdam: increase in sexually transmitted diseases and risky sexual behaviour among homosexual men in relation to the introduction of new anti-HIV drugs. Euro Surveill. 2002 Feb;7(2):19–22. doi: 10.2807/esm.07.02.00346-en. [DOI] [PubMed] [Google Scholar]
  51. Van der Heyden J. H., Catchpole M. A., Paget W. J., Stroobant A. Trends in gonorrhoea in nine western European countries, 1991-6. European Study Group. Sex Transm Infect. 2000 Apr;76(2):110–116. doi: 10.1136/sti.76.2.110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Wellings K., Nanchahal K., Macdowall W., McManus S., Erens B., Mercer C. H., Johnson A. M., Copas A. J., Korovessis C., Fenton K. A. Sexual behaviour in Britain: early heterosexual experience. Lancet. 2001 Dec 1;358(9296):1843–1850. doi: 10.1016/S0140-6736(01)06885-4. [DOI] [PubMed] [Google Scholar]
  53. Wilson J. S., Honey E., Templeton A., Paavonen J., Mårdh P. A., Stray-Pedersen B., EU Biomed Concerted Action Group A systematic review of the prevalence of Chlamydia trachomatis among European women. Hum Reprod Update. 2002 Jul-Aug;8(4):385–394. doi: 10.1093/humupd/8.4.385. [DOI] [PubMed] [Google Scholar]
  54. Wutzler P., Doerr H. W., Färber I., Eichhorn U., Helbig B., Sauerbrei A., Brandstädt A., Rabenau H. F. Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations-relevance for the incidence of genital herpes. J Med Virol. 2000 Jun;61(2):201–207. doi: 10.1002/(sici)1096-9071(200006)61:2<201::aid-jmv5>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  55. de Ory F., Pachón I., Echevarría J. M., Ramírez R. Seroepidemiological study of herpes simplex virus in the female population in the autonomous region of Madrid, Spain. Eur J Clin Microbiol Infect Dis. 1999 Sep;18(9):678–680. doi: 10.1007/s100960050377. [DOI] [PubMed] [Google Scholar]
  56. van Duynhoven Y. T. The epidemiology of Neisseria gonorrhoeae in Europe. Microbes Infect. 1999 May;1(6):455–464. doi: 10.1016/s1286-4579(99)80049-5. [DOI] [PubMed] [Google Scholar]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Publishing Group

RESOURCES